Overview
Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance
Status:
Completed
Completed
Trial end date:
2005-07-01
2005-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
THE PURPOSE OF THIS STUDY IS TO DETERMINE IF 24 WEEKS OF TREATMENT WITH VALSARTAN (80 MG - 320 MG) IMPROVES INSULIN SENSITIVITY IN SUBJECTS WITH HIGHER THAN NORMAL GLUCOSE LEVELS USING A TEST CALLED THE EUGLYCEMIC CLAMP.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
NovartisTreatments:
Insulin
Valsartan
Criteria
Inclusion Criteria:history or presenting hypertension Elevated fasting blood glucose levels -
Exclusion Criteria:
Pregnancy potential Diabetes mellitus
Other criteria apply
-